IP Verse

Oncobiologics, Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Oncobiologics, Inc. opposed by its competitors

Patent:
EP3400241
Grant Date:
Jul 22, 2020
Title:
Modulation Of Afucosylated Species In A Monoclonal Antibody Composition
Oppositions:
1

Competitors of Oncobiologics, Inc.

PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBB

Want to track Oncobiologics, Inc.?

Feel free to send us a message here and we will get back to you